Waterloo researcher helps develop database repository to assist hemophilia patients
Waterloo Pharmacy professor and doctoral student invited to discuss recent research findings in Neurology. In an age of misinformation, knowledge translation (KT) is an increasingly important way to communicate research to the audiences who need it.
The Waterloo School of Pharmacy implemented a mass vaccination clinic for COVID-19 immunization in 2021.
With many multidisciplinary teams working together in an environment not built for such a complex clinical system, researchers at the University of Waterloo created an app to support front-line workers. The app streamlined information flow to help solve logistical challenges that arose.
Waterloo School of Pharmacy researchers have found that in patients with type-2 diabetes experiencing severe hypoglycaemic events, where blood glucose levels fall below normal to potentially dangerous levels leading to either a hospitalization or physician visit, is consistently linked with the development of dementia.
Medication non-adherence is a concern globally, and often occurs unknowingly or by mistake. Dr. Tejal Patel, clinical associate professor at the University of Waterloo School of Pharmacy, is trying to improve medication management and assist older adults when taking their medication at home by correctly matching them with new innovative technologies.
A new study has found that although three-quarters of Ontario pharmacists can administer injections “vaccination deserts” do exist, areas with little to no access to pharmacist-administered vaccination sites.
To identify these areas, researchers at the University of Waterloo and Laurentian University mapped regions across Ontario. It was found that most community pharmacists authorized to administer injections are found in the urban region of Southern Ontario, confirming there is a geographic discrepancy.
A new study reveals a connection between poverty and opioid-related hospitalization, emergency department visits and deaths in Canada. From 2000 to 2017, Canada's poorest residents were 3.8 times more likely to die of opioid-related causes than Canada's richest residents.